Policy ID: a79f7821-7556-4585-8fa7-451c9b78bc10
Version: 5.9
Created At: 2025-12-06T23:05:13.420397+00:00
Last Updated: 2025-12-06T23:05:13.420397+00:00
Title: Pediatrics Infection Control Policy
Specialty: Pediatrics
Policy Type: infection-control
Complexity: medium
Approval Status: under_review
Evidence Level: Level III - Cohort Study
Review Frequency: Annually
Effective Date: 2025-12-06T23:05:13.420397+00:00
Next Review Date: 2026-12-31T00:00:00+00:00

AUTHOR:
Name: Dr. Smith Taylor
Title: Clinical Director
Department: Pediatrics Department
Email: clinical.director@hospital-573.example.com

APPROVERS:
- Name: Dr. Miller Robinson | Title: Chief Medical Officer | Department: Medical Executive Committee | Approved At: 2025-12-06T23:05:13.420397+00:00

PURPOSE:
To provide evidence-based guidance for infection control in Pediatrics practice to ensure optimal patient outcomes and standardized care delivery.

SCOPE:
Patient Populations:
- Adult patients presenting with pediatrics conditions
- Patients requiring infection control intervention

Clinical Settings:
- Emergency Department
- Inpatient Ward
- Outpatient Clinic

Exclusion Criteria:
- Pediatric patients under 18 years
- Patients with multiple comorbidities requiring specialized care

BACKGROUND:
Clinical Rationale: Current evidence supports standardized approaches to infection control in Pediatrics to improve patient safety and clinical outcomes.
Epidemiology: Approximately 34% of pediatrics cases require this type of intervention annually.
Current Evidence Summary: Multiple Level II studies demonstrate efficacy of standardized protocols in reducing adverse events and improving patient satisfaction.

CARE PATHWAY:

Phase 1: Initial Assessment (Within 30 minutes of presentation)
Description: Comprehensive patient evaluation and risk stratification

Phase 2: Treatment Planning (Within 2 hours of initial assessment)
Description: Development of individualized treatment approach
